MicroRNA‐122 can be measured in capillary blood which facilitates point‐of‐care testing for drug‐induced liver injury

AIMS: Liver‐enriched microRNA‐122 (miR‐122) is a novel circulating biomarker for drug‐induced liver injury (DILI). To date, miR‐122 has been measured in serum or plasma venous samples. If miR‐122 could be measured in capillary blood obtained from a finger prick it would facilitate point‐of‐care test...

Descripción completa

Detalles Bibliográficos
Autores principales: Vliegenthart, A. D. Bastiaan, Berends, Cécile, Potter, Carmelita M. J., Kersaudy‐Kerhoas, Maiwenn, Dear, James W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Human Toxicology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5555871/
https://www.ncbi.nlm.nih.gov/pubmed/28257154
http://dx.doi.org/10.1111/bcp.13282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5555871/
https://www.ncbi.nlm.nih.gov/pubmed/28257154
http://dx.doi.org/10.1111/bcp.13282

Ejemplares similares